Bayesian hierarchical models incorporating study-level covariates for multivariate meta-analysis of diagnostic tests without a gold standard with application to COVID-19
© 2023 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd..
When evaluating a diagnostic test, it is common that a gold standard may not be available. One example is the diagnosis of SARS-CoV-2 infection using saliva sampling or nasopharyngeal swabs. Without a gold standard, a pragmatic approach is to postulate a "reference standard," defined as positive if either test is positive, or negative if both are negative. However, this pragmatic approach may overestimate sensitivities because subjects infected with SARS-CoV-2 may still have double-negative test results even when both tests exhibit perfect specificity. To address this limitation, we propose a Bayesian hierarchical model for simultaneously estimating sensitivity, specificity, and disease prevalence in the absence of a gold standard. The proposed model allows adjusting for study-level covariates. We evaluate the model performance using an example based on a recently published meta-analysis on the diagnosis of SARS-CoV-2 infection and extensive simulations. Compared with the pragmatic reference standard approach, we demonstrate that the proposed Bayesian method provides a more accurate evaluation of prevalence, specificity, and sensitivity in a meta-analytic framework.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
Statistics in medicine - 42(2023), 28 vom: 10. Dez., Seite 5085-5099 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Zheng [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bayesian hierarchical model |
---|
Anmerkungen: |
Date Completed 02.02.2024 Date Revised 03.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/sim.9902 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362216029 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM362216029 | ||
003 | DE-627 | ||
005 | 20240203231852.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/sim.9902 |2 doi | |
028 | 5 | 2 | |a pubmed24n1279.xml |
035 | |a (DE-627)NLM362216029 | ||
035 | |a (NLM)37724773 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Zheng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bayesian hierarchical models incorporating study-level covariates for multivariate meta-analysis of diagnostic tests without a gold standard with application to COVID-19 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.02.2024 | ||
500 | |a Date Revised 03.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. | ||
520 | |a When evaluating a diagnostic test, it is common that a gold standard may not be available. One example is the diagnosis of SARS-CoV-2 infection using saliva sampling or nasopharyngeal swabs. Without a gold standard, a pragmatic approach is to postulate a "reference standard," defined as positive if either test is positive, or negative if both are negative. However, this pragmatic approach may overestimate sensitivities because subjects infected with SARS-CoV-2 may still have double-negative test results even when both tests exhibit perfect specificity. To address this limitation, we propose a Bayesian hierarchical model for simultaneously estimating sensitivity, specificity, and disease prevalence in the absence of a gold standard. The proposed model allows adjusting for study-level covariates. We evaluate the model performance using an example based on a recently published meta-analysis on the diagnosis of SARS-CoV-2 infection and extensive simulations. Compared with the pragmatic reference standard approach, we demonstrate that the proposed Bayesian method provides a more accurate evaluation of prevalence, specificity, and sensitivity in a meta-analytic framework | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Bayesian hierarchical model | |
650 | 4 | |a SARS-CoV-2 infection diagnosis | |
650 | 4 | |a diagnostic test | |
650 | 4 | |a double negatives | |
650 | 4 | |a meta-analysis | |
650 | 4 | |a sensitivity | |
650 | 4 | |a specificity | |
700 | 1 | |a Murray, Thomas A |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Mengli |e verfasserin |4 aut | |
700 | 1 | |a Lin, Lifeng |e verfasserin |4 aut | |
700 | 1 | |a Alemayehu, Demissie |e verfasserin |4 aut | |
700 | 1 | |a Chu, Haitao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Statistics in medicine |d 1984 |g 42(2023), 28 vom: 10. Dez., Seite 5085-5099 |w (DE-627)NLM012664596 |x 1097-0258 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2023 |g number:28 |g day:10 |g month:12 |g pages:5085-5099 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/sim.9902 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 42 |j 2023 |e 28 |b 10 |c 12 |h 5085-5099 |